de Greeff Annemarie, Shennan Andrew H
Medical Research and Device Validation Consultant, Validate Global, Kimberley, South Africa and Division of Women's Health, King's College London, UK.
Professor of Obstetrics, Validate Global, Kimberley, South Africa and Division of Women's Health, King's College London, UK
Trop Doct. 2015 Jul;45(3):168-73. doi: 10.1177/0049475515581542. Epub 2015 Apr 23.
Hypertensive disorders of pregnancy cause significant maternal morbidity and mortality worldwide, particularly in developing countries. This study evaluated the accuracy of the Nissei DS-400, a low cost blood pressure (BP) device, in pregnancy according to the British Hypertension Society protocol. Forty-five pregnant women (15 with pre-eclampsia), were recruited from a large teaching hospital. Nine sequential same-arm BP measurements were taken from each woman by trained observers, alternating between mercury sphygmomanometry and the device. The Nissei DS-400 achieved the highest accuracy grade (A/A) in all subjects (n = 45) and in pregnancy alone (n = 30). The mean difference ± standard deviation between the standard and the device in pregnancy were -1.0 ± 5.1 mmHg and -1.1 ± 5.0 mmHg for systolic and diastolic BP, respectively, and -2.6 ± 5.9 mmHg and -3.4 ± 5.8 mmHg in all subjects. The Nissei-DS 400 can be recommended for clinical use in pregnancy and has potential as a good screening tool for pre-eclampsia in low resource settings.
妊娠高血压疾病在全球范围内,尤其是在发展中国家,会导致严重的孕产妇发病和死亡。本研究根据英国高血压学会的方案,评估了低成本血压测量设备Nissei DS - 400在孕期使用的准确性。从一家大型教学医院招募了45名孕妇(其中15名患有先兆子痫)。由经过培训的观察员对每位女性进行9次连续的同侧血压测量,在水银血压计和该设备之间交替使用。Nissei DS - 400在所有受试者(n = 45)以及仅在孕期的受试者(n = 30)中均达到了最高准确性等级(A/A)。孕期标准测量值与该设备测量值之间的平均差值±标准差,收缩压分别为-1.0±5.1 mmHg和-1.1±5.0 mmHg,舒张压分别为-2.6±5.9 mmHg和-3.4±5.8 mmHg。Nissei - DS 400可推荐用于孕期临床,并且在资源匮乏地区有潜力成为先兆子痫的良好筛查工具。